BBIO
BridgeBio Pharma Inc
$66.20
0.00 (0.00%) Today
0.23 (0.35%) Pre-market
— up— down
Market Cap
$12.90B+27.0%
Revenue (TTM)
$713.34M+202.4%
Net Income (TTM)
$-698,926,410
$-698,926,410EPS (TTM)
-3.57
-3.57Shares Out
195.86M
195.86MOpen
$65.97
$65.97Previous Close
$65.97
$65.97Day Range
$65.82 – $67.15
$65.82 – $67.1552-Week Range
$51.85 – $93.42
$51.85 – $93.42Beta
0.97
0.97Volume
3.56M
3.56MAvg Volume
3.04M
3.04MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout BBIO
Related
News
Alnylam Pharmaceuticals: More Than Meets The Eye After CARDIO-TTRansform
SeekingAlpha · 1d ago
The Bull Case For BridgeBio Pharma (BBIO) Could Change Following New ATTR Data Versus Tafamidis
Yahoo · 2d ago
BridgeBio Pharma (BBIO) Stock Looks Reasonable As Fresh Acoramidis Data Lands
Yahoo · 2d ago
BridgeBio Pharma Eyes Four Global Launches by 2027 as Attruby Nears Blockbuster Status
Yahoo · 4d ago
BridgeBio Pharma, Inc. (BBIO) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript
SeekingAlpha · 6d ago